Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 1
2005 1
2006 5
2007 4
2008 7
2009 2
2010 3
2011 3
2013 4
2014 2
2015 1
2016 1
2017 2
2018 4
2019 2
2020 4
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. El Hussein S, et al. Among authors: schlette e. Pathology. 2023 Jun;55(4):514-524. doi: 10.1016/j.pathol.2022.12.354. Epub 2023 Feb 25. Pathology. 2023. PMID: 36933995
Epstein-Barr virus-positive follicular lymphoma.
Kurt H, Medeiros LJ, Khoury JD, Schlette EJ. Kurt H, et al. Among authors: schlette ej. Br J Haematol. 2018 Sep;182(6):757. doi: 10.1111/bjh.15419. Epub 2018 May 29. Br J Haematol. 2018. PMID: 29808924 Free article. No abstract available.
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. El Hussein S, et al. Among authors: schlette e. Virchows Arch. 2023 Jun;482(6):1011-1019. doi: 10.1007/s00428-023-03520-x. Epub 2023 Mar 3. Virchows Arch. 2023. PMID: 36864257
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.
Fang H, Wang SA, You MJ, Hu S, Miranda RN, Tang Z, Lin P, Jorgensen JL, Xu J, Thakral B, Schlette EJ, El Hussein S, Bueso-Ramos C, Medeiros LJ, Wang W. Fang H, et al. Among authors: schlette ej. Cytometry B Clin Cytom. 2022 Nov;102(6):440-447. doi: 10.1002/cyto.b.22095. Epub 2022 Sep 26. Cytometry B Clin Cytom. 2022. PMID: 36156384 Free article.
Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.
Strati P, Schlette EJ, Solis Soto LM, Duenas DE, Sivina M, Kim E, Keating MJ, Wierda WG, Ferrajoli A, Kantarjian H, Estrov Z, Jain N, Thompson PA, Wistuba II, Burger JA. Strati P, et al. Among authors: schlette ej. Blood. 2020 Feb 13;135(7):510-513. doi: 10.1182/blood.2019003570. Blood. 2020. PMID: 31895947 Free PMC article. Clinical Trial. No abstract available.
50 results